TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive DCPC Board Ponders Screening Recommendations: Should NCI Have Policies? If So, What Will They Be? September 26, 1986